Qualigen Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $2,237 | $0 | $0 |
Gross Profit | 1,118 | -123 | ||
EBITDA | -1,579 | -749 | -1,387 | |
EBIT | -1,683 | -1,333 | -973 | -1,389 |
Net Income | -1,685 | -855 | -855 | -1,794 |
Net Change In Cash | 0 | 2,237 | 0 | 0 |
Free Cash Flow | -1,098 | -2,269 | -2,269 | -1,799 |
Cash | 331 | 1,174 | 1,174 | 388 |
Basic Shares | 1,683 | 736 | 387 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $5,204 | $4,983 | $5,653 |
Gross Profit | -4 | 680 | 1,321 | |
EBITDA | -5,243 | -11,300 | -13,841 | -22,663 |
EBIT | -5,761 | -11,304 | -13,853 | -22,985 |
Net Income | -6,159 | -13,417 | -21,034 | -17,897 |
Net Change In Cash | 0 | 5,204 | 4,983 | 5,653 |
Free Cash Flow | -6,327 | -10,304 | -13,566 | -14,872 |
Cash | 1,174 | 401 | 7,034 | 17,538 |
Basic Shares | 361 | 5,072 | 3,840 | 2,933 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$1.00 |
2025-03-31 | -$1.09 |
2024-12-31 | -$1.16 |
2024-09-30 | -$4.69 |
